148 related articles for article (PubMed ID: 19519376)
21. Factors affecting serum protein binding of cocaine in humans.
Parker RB; Williams CL; Laizure SC; Lima JJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
[TBL] [Abstract][Full Text] [Related]
22. Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs.
Finlay GJ; Baguley BC
Cancer Chemother Pharmacol; 2000; 45(5):417-22. PubMed ID: 10803926
[TBL] [Abstract][Full Text] [Related]
23. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
Wanwimolruk S; Denton JR
J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the "zero crossing" method in derivative spectroscopy and ultrafiltration for the determination of free and bound fractions of mitoxantrone.
Maia MB; Tufenkji AE; Rochas MA; Saivin S; Houin G
Fundam Clin Pharmacol; 1994; 8(2):178-84. PubMed ID: 8020875
[TBL] [Abstract][Full Text] [Related]
25. Binding of cosalane--a novel highly lipophilic anti-HIV agent--to albumin and glycoprotein.
Kuchimanchi KR; Ahmed MS; Johnston TP; Mitra AK
J Pharm Sci; 2001 May; 90(5):659-66. PubMed ID: 11288110
[TBL] [Abstract][Full Text] [Related]
26. A molecular functional study on the interactions of drugs with plasma proteins.
Otagiri M
Drug Metab Pharmacokinet; 2005 Oct; 20(5):309-23. PubMed ID: 16272748
[TBL] [Abstract][Full Text] [Related]
27. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
[TBL] [Abstract][Full Text] [Related]
28. Investigation of binding mechanism of novel 8-substituted coumarin derivatives with human serum albumin and α-1-glycoprotein.
Yeggoni DP; Manidhar DM; Suresh Reddy C; Subramanyam R
J Biomol Struct Dyn; 2016 Sep; 34(9):2023-36. PubMed ID: 26440860
[TBL] [Abstract][Full Text] [Related]
29. Imatinib binding to human serum albumin modulates heme association and reactivity.
Di Muzio E; Polticelli F; Trezza V; Fanali G; Fasano M; Ascenzi P
Arch Biochem Biophys; 2014 Oct; 560():100-12. PubMed ID: 25057771
[TBL] [Abstract][Full Text] [Related]
30. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
Mazoit JX; Cao LS; Samii K
J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
[TBL] [Abstract][Full Text] [Related]
31. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
Zini R; Morin D; Salvadori C; Tillement JP
Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
[TBL] [Abstract][Full Text] [Related]
32. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
33. In vitro plasma protein binding and aqueous aggregation behavior of astaxanthin dilysinate tetrahydrochloride.
Zsila F; Fitos I; Bikádi Z; Simonyi M; Jackson HL; Lockwood SF
Bioorg Med Chem Lett; 2004 Nov; 14(21):5357-66. PubMed ID: 15454227
[TBL] [Abstract][Full Text] [Related]
34. Characterization of binding mode of imatinib to human α1-acid glycoprotein.
Fitos I; Simon Á; Zsila F; Mády G; Bencsura Á; Varga Z; Orfi L; Kéri G; Visy J
Int J Biol Macromol; 2012 Apr; 50(3):788-95. PubMed ID: 22142793
[TBL] [Abstract][Full Text] [Related]
35. The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.
Veering BT; Burm AG; Souverijn JH; Serree JM; Spierdijk J
Br J Clin Pharmacol; 1990 Feb; 29(2):201-6. PubMed ID: 2306411
[TBL] [Abstract][Full Text] [Related]
36. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
Baruzzi A; Contin M; Perucca E; Albani F; Riva R
Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833
[TBL] [Abstract][Full Text] [Related]
37. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
Jackson PR; Tucker GT; Woods HF
Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
[TBL] [Abstract][Full Text] [Related]
38. Protopine and Allocryptopine Interactions with Plasma Proteins.
Marciniak A; Kotynia A; Krzyżak E; Czyżnikowska Ż; Zielińska S; Kozłowska W; Białas M; Matkowski A; Jezierska-Domaradzka A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791436
[TBL] [Abstract][Full Text] [Related]
39. Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method.
Zhang HX; Xiong HX; Li LW
Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():88-94. PubMed ID: 26963729
[TBL] [Abstract][Full Text] [Related]
40. Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.
Brunner F; Müller WE
J Pharm Pharmacol; 1985 May; 37(5):305-9. PubMed ID: 2862237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
